These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3415201)

  • 1. Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism.
    Sage JI; Trooskin S; Sonsalla PK; Heikkila R; Duvoisin RC
    Ann Neurol; 1988 Jul; 24(1):87-9. PubMed ID: 3415201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease.
    Sage JI; Schuh L; Heikkila RE; Duvoisin RC
    Clin Neuropharmacol; 1988 Feb; 11(1):36-44. PubMed ID: 3349496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations.
    Kurlan R; Rubin AJ; Miller C; Rivera-Calimlim L; Clarke A; Shoulson I
    Ann Neurol; 1986 Aug; 20(2):262-5. PubMed ID: 3752968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.
    Sage JI; Sonsalla PK; McHale DM; Heikkila RE; Duvoisin RC
    Adv Neurol; 1990; 53():383-6. PubMed ID: 2122646
    [No Abstract]   [Full Text] [Related]  

  • 5. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure.
    Nyholm D; Lewander T; Johansson A; Lewitt PA; Lundqvist C; Aquilonius SM
    Clin Neuropharmacol; 2008; 31(2):63-73. PubMed ID: 18382177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.
    Nyholm D
    Expert Rev Neurother; 2006 Oct; 6(10):1403-11. PubMed ID: 17078781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease.
    Nutt JG; Carter JH; Lea ES; Woodward WR
    Mov Disord; 1997 May; 12(3):285-92. PubMed ID: 9159720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI; Mark MH
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations.
    Nyholm D; Constantinescu R; Holmberg B; Dizdar N; Askmark H
    Acta Neurol Scand; 2009 May; 119(5):345-8. PubMed ID: 18822087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous treatment with levodopa of Parkinson disease].
    Lundqvist C; Nystedt T; Reiertsen O; Grotli R; Beiske AG
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2638-40. PubMed ID: 16215609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions.
    Nutt JG; Carter JH; Woodward W; Hammerstad JP; Gancher ST
    Mov Disord; 1993 Apr; 8(2):139-43. PubMed ID: 8474479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa.
    Metman LV; Hoff J; Mouradian MM; Chase TN
    Mov Disord; 1994 Jul; 9(4):463-5. PubMed ID: 7969216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.
    Devos D;
    Mov Disord; 2009 May; 24(7):993-1000. PubMed ID: 19253412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease.
    Syed N; Murphy J; Zimmerman T; Mark MH; Sage JI
    Mov Disord; 1998 Mar; 13(2):336-8. PubMed ID: 9539350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with continuous enteral levodopa infusions in the treatment of 9 patients with advanced Parkinson's disease.
    Sage JI; Trooskin S; Sonsalla PK; Heikkila RE
    Neurology; 1989 Nov; 39(11 Suppl 2):60-3; discussion 72-3. PubMed ID: 2586763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease.
    Nilsson D; Hansson LE; Johansson K; Nyström C; Paalzow L; Aquilonius SM
    Acta Neurol Scand; 1998 Mar; 97(3):175-83. PubMed ID: 9531434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.
    Blindauer K; Shoulson I; Oakes D; Kieburtz K; Schwid S; Fahn S; Stern M; Goetz C; Nutt J; Goren S; Sayag N; Scolnik M; Levy R; Eyal E; Salzman P; Pagano M;
    Arch Neurol; 2006 Feb; 63(2):210-6. PubMed ID: 16476809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
    Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
    Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.
    Antonini A; Isaias IU; Canesi M; Zibetti M; Mancini F; Manfredi L; Dal Fante M; Lopiano L; Pezzoli G
    Mov Disord; 2007 Jun; 22(8):1145-9. PubMed ID: 17661426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.